Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Diabetes complications and comorbidities: Hyperglycemia

Journal articles and book chapters

28-05-2018 | Risk factors | Article

Diabetes risk scores for Hispanics living in the United States: A systematic review

Juarez LD et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.05.009

22-05-2018 | Cardiovascular disorders | Article

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes

Matsutani D et al. Cardiovasc Diabetol 2018; 17: 73. doi: 10.1186/s12933-018-0717-9

18-05-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

18-05-2018 | Gestational diabetes | Review | Article

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3

17-05-2018 | Gestational diabetes | Article

Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial

Fraticelli F et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1157-4

15-05-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

14-05-2018 | Insulin glargine | Article

Characteristics of insulin-naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: A meta-analysis of individual participant data from 3 randomized clinical trials

Cummings MH et al. Clin Diabetes Endocrinol 2018; 4: 10. doi: 10.1186/s40842-018-0059-2

10-05-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

09-05-2018 | Sleep apnea | Review | Article

Maternal non-glycemic contributors to fetal growth in obesity and gestational diabetes: Spotlight on lipids

Barbour LA, Hernandez TL. Curr Diab Rep 2018; 18: 37. doi: 10.1007/s11892-018-1008-2

08-05-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: Do oral agents have a place?

Corcoy R et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.015

05-05-2018 | Physical activity | Review | Article

May the force be with you: Why resistance training is essential for subjects with type 2 diabetes mellitus without complications

Codella R et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1603-7

04-05-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: The bright and dark sides

Lapolla A, Metzger BE. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1146-7

03-05-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

Toledano Y, Hadar E, Hod M. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

28-04-2018 | Heart failure | Review | Article

SGLT2 inhibition and heart failure: Current concepts

Custodio JS et al. Heart Fail Rev 2018; 23: 409–418. doi: 10.1007/s10741-018-9703-2

18-04-2018 | Pregnancy | Review | Article

Hyperglycemia in pregnancy and its implications for a woman’s future risk of cardiovascular disease

Retnakaran R. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.008

16-04-2018 | Type 1 diabetes | Review | Article

The potential role of SGLT2 inhibitors in the treatment of type 1 diabetes mellitus

Fattah H, Vallon, V. Drugs 2018; 78: 717–726. doi: 10.1007/s40265-018-0901-y

24-03-2018 | GLP-1 agonists | Review | Article

Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification

Trautmann ME, Vora J. Diabet Med 2018; Advance online publication. doi: 10.1111/dme.13610

26-02-2018 | Hyperglycemia | Review | Article

Critical care management of stress-induced hyperglycemia

Vanhorebeek I, Gunst J, Van den Berghe G. Curr Diab Rep 2018; 18: 17. doi: 10.1007/s11892-018-0988-2

21-02-2018 | Medication adherence | Article

The influence of pharmacist-led adherence support on glycemic control in people with type 2 diabetes

Kharjul M, Braund R, Green J. Int J Clin Pharm 2018; Advance online publication. doi: 10.1007/s11096-018-0606-z

19-02-2018 | Nephropathy | Review | Article

The landscape of diabetic kidney disease in the United States

Duru OK et al. Curr Diab Rep 2018; 18: 14. doi: 10.1007/s11892-018-0980-x

Next Previous
Image Credits